John Long
Plus aucun poste en cours
Profil
John Long served as Chief Financial Officer & Director at I-Mab in 2021-2022.
Prior to that, he held the same position at WuXi AppTec Co., Ltd., Genecast Biotechnology Co. Ltd., Stemirna Therapeutics Co., Ltd., and WuXi NextCODE Genomics (Shanghai) Co., Ltd.
Mr. Long received his undergraduate degree from the University of International Business & Economics in 1994 and his MBA from The Wharton School of the University of Pennsylvania in 2001.
Anciens postes connus de John Long
| Sociétés | Poste | Fin |
|---|---|---|
| I-MAB | Directeur Financier/CFO | 30/09/2022 |
Stemirna Therapeutics Co., Ltd.
 Stemirna Therapeutics Co., Ltd. Packaged SoftwareTechnology Services Stemirna Therapeutics Co., Ltd. is a clinical-stage mRNA biopharmaceutical company based in Shanghai, China, and with additional locations. The Chinese company has developed a broad portfolio of novel mRNA-based vaccines and therapeutics with a focus on infectious disease and oncology, utilizing a proprietary LPP delivery system. Stemirna's lead product candidate is an mRNA COVID-19 vaccine, currently in clinical stages in multiple countries. The company also has in-house CMC and manufacturing capabilities and advanced capacity in Shanghai. The company was founded in 2016 by Ding Guo Tang, Hang Wen Li, and Hai Fa Shen, with Hang Wen Li serving as CEO since then. | Directeur Financier/CFO | - |
Genecast Biotechnology Co. Ltd.
 Genecast Biotechnology Co. Ltd. Hospital/Nursing ManagementHealth Services Genecast Biotechnology Co. Ltd. is a Chinese company that operates in the field of cancer diagnosis. The company is based in Beijing, China. It was founded in 2014 and the CEO is Bo Du. | Directeur Financier/CFO | - |
| WuXi NextCODE Genomics (Shanghai) Co., Ltd | Directeur Financier/CFO | - |
| WUXI APPTEC CO., LTD. | Directeur Financier/CFO | - |
Formation de John Long
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| University of International Business & Economics | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| I-MAB | Health Technology |
| WUXI APPTEC CO., LTD. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| WuXi NextCODE Genomics (Shanghai) Co., Ltd | |
Genecast Biotechnology Co. Ltd.
Genecast Biotechnology Co. Ltd. Hospital/Nursing ManagementHealth Services Genecast Biotechnology Co. Ltd. is a Chinese company that operates in the field of cancer diagnosis. The company is based in Beijing, China. It was founded in 2014 and the CEO is Bo Du. | Health Services |
Stemirna Therapeutics Co., Ltd.
Stemirna Therapeutics Co., Ltd. Packaged SoftwareTechnology Services Stemirna Therapeutics Co., Ltd. is a clinical-stage mRNA biopharmaceutical company based in Shanghai, China, and with additional locations. The Chinese company has developed a broad portfolio of novel mRNA-based vaccines and therapeutics with a focus on infectious disease and oncology, utilizing a proprietary LPP delivery system. Stemirna's lead product candidate is an mRNA COVID-19 vaccine, currently in clinical stages in multiple countries. The company also has in-house CMC and manufacturing capabilities and advanced capacity in Shanghai. The company was founded in 2016 by Ding Guo Tang, Hang Wen Li, and Hai Fa Shen, with Hang Wen Li serving as CEO since then. | Technology Services |
